Patients-specific metaclusters displayed a trend for higher expression of CD38 (median 46.28% vs 24.64% in HD-metaclusters) and HLA-DR (median 12.51% vs 7.12% in HD-metaclusters), suggesting that these T cells were recently activated. This evidence concerns the gene CD38 and Huntington disease.